These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 11495592)

  • 1. Methylated analogues of methyl (R)-4-(3,4-dichlorophenylacetyl)- 3-(pyrrolidin-1-ylmethyl)piperazine-1-carboxylate (GR-89,696) as highly potent kappa-receptor agonists: stereoselective synthesis, opioid-receptor affinity, receptor selectivity, and functional studies.
    Soukara S; Maier CA; Predoiu U; Ehret A; Jackisch R; Wünsch B
    J Med Chem; 2001 Aug; 44(17):2814-26. PubMed ID: 11495592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and stereoselective kappa-receptor binding of methylated analogues of GR-89.696.
    Röhr C; Soukara S; Wünsch B
    Eur J Med Chem; 2001 Feb; 36(2):211-4. PubMed ID: 11311752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformationally restricted κ-opioid receptor agonists: Synthesis and pharmacological evaluation of diastereoisomeric and enantiomeric decahydroquinoxalines.
    Molenveld P; Bouzanne des Mazery R; Sterk GJ; Storcken RP; Autar R; van Oss B; van der Haas RN; Fröhlich R; Schepmann D; Wünsch B; Soeberdt M
    Bioorg Med Chem Lett; 2015 Nov; 25(22):5326-30. PubMed ID: 26411794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probes for narcotic receptor mediated phenomena. 17. Synthesis and evaluation of a series of trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzeneacet amide (U50,488) related isothiocyanate derivatives as opioid receptor affinity ligands.
    de Costa BR; Rothman RB; Bykov V; Band L; Pert A; Jacobson AE; Rice KC
    J Med Chem; 1990 Apr; 33(4):1171-6. PubMed ID: 2157008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereoselective synthesis and structure-affinity relationships of bicyclic kappa receptor agonists.
    Kracht D; Rack E; Schepmann D; Fröhlich R; Wünsch B
    Org Biomol Chem; 2010 Jan; 8(1):212-25. PubMed ID: 20024152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors influencing agonist potency and selectivity for the opioid delta receptor are revealed in structure-activity relationship studies of the 4-[(N-substituted-4-piperidinyl)arylamino]-N,N-diethylbenzamides.
    Thomas JB; Herault XM; Rothman RB; Atkinson RN; Burgess JP; Mascarella SW; Dersch CM; Xu H; Flippen-Anderson JL; George CF; Carroll FI
    J Med Chem; 2001 Mar; 44(6):972-87. PubMed ID: 11300879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in the stereochemistry of the kappa-selective opioid agonist U50,488 result in high-affinity sigma ligands.
    de Costa BR; Bowen WD; Hellewell SB; George C; Rothman RB; Reid AA; Walker JM; Jacobson AE; Rice KC
    J Med Chem; 1989 Aug; 32(8):1996-2002. PubMed ID: 2547074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A potent new class of kappa-receptor agonist: 4-substituted 1-(arylacetyl)-2-[(dialkylamino)methyl]piperazines.
    Naylor A; Judd DB; Lloyd JE; Scopes DI; Hayes AG; Birch PJ
    J Med Chem; 1993 Jul; 36(15):2075-83. PubMed ID: 8393489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
    Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
    J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probes for narcotic receptor-mediated phenomena. 25. Synthesis and evaluation of N-alkyl-substituted (alpha-piperazinylbenzyl)benzamides as novel, highly selective delta opioid receptor agonists.
    Katsura Y; Zhang X; Homma K; Rice KC; Calderon SN; Rothman RB; Yamamura HI; Davis P; Flippen-Anderson JL; Xu H; Becketts K; Foltz EJ; Porreca F
    J Med Chem; 1997 Aug; 40(18):2936-47. PubMed ID: 9288176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probes for narcotic receptor mediated phenomena. 23. Synthesis, opioid receptor binding, and bioassay of the highly selective delta agonist (+)-4-[(alpha R)-alpha-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]- N,N-diethylbenzamide (SNC 80) and related novel nonpeptide delta opioid receptor ligands.
    Calderon SN; Rice KC; Rothman RB; Porreca F; Flippen-Anderson JL; Kayakiri H; Xu H; Becketts K; Smith LE; Bilsky EJ; Davis P; Horvath R
    J Med Chem; 1997 Feb; 40(5):695-704. PubMed ID: 9057856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New diarylmethylpiperazines as potent and selective nonpeptidic delta opioid receptor agonists with increased In vitro metabolic stability.
    Plobeck N; Delorme D; Wei ZY; Yang H; Zhou F; Schwarz P; Gawell L; Gagnon H; Pelcman B; Schmidt R; Yue SY; Walpole C; Brown W; Zhou E; Labarre M; Payza K; St-Onge S; Kamassah A; Morin PE; Projean D; Ducharme J; Roberts E
    J Med Chem; 2000 Oct; 43(21):3878-94. PubMed ID: 11052793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and structure-opioid activity relationships of trans-(+/-)-3,4-dichloro-N-methyl-N-[4- or 5-hydroxy-2-(1-pyrrolidiny)cyclohexyl]benzeneacetamides.
    Cheng CY; Chen CY; Tao PL
    J Pharm Pharmacol; 1997 Sep; 49(9):835-42. PubMed ID: 9306249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of mu, kappa, and delta opioid binding in amphibian whole brain tissue homogenates.
    Newman LC; Sands SS; Wallace DR; Stevens CW
    J Pharmacol Exp Ther; 2002 Apr; 301(1):364-70. PubMed ID: 11907194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel ligands for the opioid receptors: synthesis and structure-activity relationships among 5'-aryl and 5'-heteroaryl 17-cyclopropylmethyl-4,5 alpha-epoxypyrido[2',3':6,7]morphinans.
    Ananthan S; Khare NK; Saini SK; Davis P; Dersch CM; Porreca F; Rothman RB
    Bioorg Med Chem; 2003 Sep; 11(18):4143-54. PubMed ID: 12927876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agonists and antagonists bind to different domains of the cloned kappa opioid receptor.
    Kong H; Raynor K; Yano H; Takeda J; Bell GI; Reisine T
    Proc Natl Acad Sci U S A; 1994 Aug; 91(17):8042-6. PubMed ID: 8058754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of cyclohexane and piperazine based κ-opioid receptor agonists: Synthesis and pharmacological evaluation of trans,trans-configured perhydroquinoxalines.
    Bourgeois C; Werfel E; Schepmann D; Wünsch B
    Bioorg Med Chem; 2014 Jul; 22(13):3316-24. PubMed ID: 24856182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and pharmacological evaluation of 5-pyrrolidinylquinoxalines as a novel class of peripherally restricted κ-opioid receptor agonists.
    Bourgeois C; Werfel E; Galla F; Lehmkuhl K; Torres-Gómez H; Schepmann D; Kögel B; Christoph T; Straßburger W; Englberger W; Soeberdt M; Hüwel S; Galla HJ; Wünsch B
    J Med Chem; 2014 Aug; 57(15):6845-60. PubMed ID: 25062506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of (1',2'-trans)-3-phenyl-1-[2'-(N-pyrrolidinyl)cyclohexyl]pyrrolid -2-ones as kappa-selective opiates.
    Cheng CY; Lu HY; Lee FM; Tam SW
    J Pharm Sci; 1990 Aug; 79(8):758-62. PubMed ID: 2172511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformationally constrained kappa receptor agonists: stereoselective synthesis and pharmacological evaluation of 6,8-diazabicyclo[3.2.2]nonane derivatives.
    Geiger C; Zelenka C; Lehmkuhl K; Schepmann D; Englberger W; Wünsch B
    J Med Chem; 2010 May; 53(10):4212-22. PubMed ID: 20441176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.